Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Colonic Neoplasms × avelumab × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Urinary Bladder Neoplasms 9 Pancreatic Neoplasms 6 Carcinoma, Merkel Cell 5 Ovarian Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Cancer Resectable 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Microsatellite Instability 1 Metastatic Urothelial Cell Cancer 1 Metastatic Castration-resistant Prostate Cancer 1

Interventions

Oxaliplatin 23 Irinotecan 23 Fluorouracil 23 Leucovorin 21 Bevacizumab 21 Capecitabine 17 Cetuximab 13 Radiotherapy 5 Immunohistochemistry 4 Folfox protocol 4 Colonoscopy 4 Mitomycin 3 Gene Expression Profiling 3 Gemcitabine 3 Doxorubicin 3 Cisplatin 3 Cholecalciferol 3 Aspirin 3 Amplified Fragment Length Polymorphism Analysis 3 ixabepilone 2 cediranib 2 adagrasib 2 Tea 2 Surveys and Questionnaires 2 Sulindac 2 Stents 2 Reverse Transcriptase Polymerase Chain Reaction 2 Receptor Protein-Tyrosine Kinases 2 Radiofrequency Ablation 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03827044 2022-10-07

POLEM

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡